FDA Just Approved the World’s Most Expensive Drug
…that will cost $2.1 million. The Food and Drug Administration (FDA) recently approved a gene therapy drug for a form of spinal muscular atrophy (SMA). Novartis is pricing the drug, Zolgensma, at $2.125 million, or $425,000 per year for five years. The drug is meant to treat children under 2 years of age with SMA, […]